Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Taiwan Sci-Tech Weekly.
Press releases published on August 7, 2025
reAlpha Mortgage Expands Footprint into Utah, Strengthens Team with Industry Leader
GlobeNewswire
·
August 7, 2025
COLUMBUS, Ohio, Aug. 07, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), an AI-powered real estate technology company, today announced the expansion of its mortgage division, reAlpha Mortgage, into Utah, a key …
Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
August 7, 2025
– On track to initiate FIH study with STRO-004, potential best-in-class Tissue Factor ADC, in the second half of 2025 – – Expanded breadth of preclinical data across pipeline, including STRO-006 and dual-payload ADCs – – Entered research collaboration with …
Elicio Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
GlobeNewswire
·
August 7, 2025
Recent positive recommendation by the Independent Data Monitoring Committee (“IDMC”) to continue ELI-002 7P randomized Phase 2 study in pancreatic cancer without modifications to final analysis Event-driven final analysis focused on disease-free survival …
Annexon Selected by EMA to Participate in Product Development Coordinator Pilot for Vonaprument (ANX007) for Dry Age-Related Macular Degeneration with Geographic Atrophy
GlobeNewswire
·
August 7, 2025
New Pilot Appoints Designated Product Development Coordinator to Navigate Regulatory Interactions, Respond to Ad-hoc Queries, and Support Evidence Planning Vonaprument Selected by EMA as One of ~20 PRIME Development Programs in the Pilot Vonaprument Has …
Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates
GlobeNewswire
·
August 7, 2025
WESTLAKE VILLAGE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the second quarter of 2025 and provided general business updates. Momentum …
ARRAY Technologies, Inc. Reports Financial Results for the Second Quarter 2025
GlobeNewswire
·
August 7, 2025
2025 Second Quarter Highlights Revenue of $362.2 million Gross Margin of 26.8% Adjusted gross margin(1) of 27.8% Net income to common shareholders of $28.5 million Adjusted EBITDA(1) of $63.6 million Net income per basic and diluted share of $0.19 Adjusted …
ESCO Reports Third Quarter Fiscal 2025 Results
GlobeNewswire
·
August 7, 2025
St. Louis, Aug. 07, 2025 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the third quarter ended June 30, 2025 (Q3 2025). On July 21, 2025, the Company announced that it had completed …
Microchip Technology Announces Financial Results for First Quarter of Fiscal Year 2026
GlobeNewswire
·
August 7, 2025
For the quarter ended June 30, 2025 Net sales of $1.0755 billion, increased 10.8% sequentially and declined 13.4% from the year ago quarter. The midpoint of our updated guidance provided on May 29, 2025 was net sales of $1.0575 billion. On a GAAP basis: …
Microchip Technology Announces Quarterly Cash Dividend on Common Stock of 45.5 Cents Per Share
GlobeNewswire
·
August 7, 2025
CHANDLER, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that its Board of Directors declared a quarterly cash …
Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference
GlobeNewswire
·
August 7, 2025
DURHAM, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Bioventus President and Chief Executive Officer, will participate in a fireside chat at the …
First LLM with Infinite Context Attention is here, wiping out $1.2 billion RAG market value by allowing AI to live outside the Matrix
GlobeNewswire
·
August 7, 2025
SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Silicon Valley startup, iFrame™ AI, has quietly secured a nearly $20 million deal with a leading cloud provider to launch the world’s first Large Attention Model with an infinite context window - a …
CytomX Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 7, 2025
- May 12, 2025 announcement of positive interim data from ongoing Phase 1 study of CX-2051 (EpCAM Antibody Drug Conjugate) in patients with advanced colorectal cancer (CRC) - - CX-2051 Phase 1 dose expansions on track for data update in Q1 2026. Phase 2 …
KLEEN HY-DRO-GEN INC., Announces Launch of World’s first Zero-Emissions Hydrogen Furnace
GlobeNewswire
·
August 7, 2025
TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- KLEEN HY-DRO-GEN INC., ( the “Company”)a Canadian clean energy company, has officially announced the public launch of KLEENHEAT™ hydrogen furnace, the world’s first and only On-Demand, Zero-Emissions home heating …
Biodesix Announces Second Quarter 2025 Results and Highlights
GlobeNewswire
·
August 7, 2025
Q2 2025 Revenue of $20.0 million, an increase of 12% over Q2 2024; Q2 2025 gross profit margin of 80%, a 150-basis point improvement from Q2 2024; Reiterating FY2025 Total Revenue Guidance of $80-85 million; Conference Call and Webcast Today at 4:30 p.m. …
Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 7, 2025
CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced that on August 4, 2025, Apyx granted a nonstatuatory stock option to purchase 100,000 shares of common stock to John …
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 7, 2025
-- Recorded $128.9 Million in Fiscal 2025 Revenue, Meeting Full-Year Guidance; Maintains Commitment to Mid-Term Outlook -- -- Nine New Programs Signed with New Customers During Fiscal 2025, Reflecting Growth into Modalities Beyond the Company's Traditional …
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates
GlobeNewswire
·
August 7, 2025
Presented updated data at ASCO showing consistency with prior data, including 10.3-month median PFS and 39% ORR in patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer Initiated Phase 3 ReDiscover-2 trial in Q2 Approximately $657 million in cash …
INmune Bio Inc. Announces Second Quarter 2025 Results, Provides Business Update and Announces Management Changes
GlobeNewswire
·
August 7, 2025
BOCA RATON, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announces its …
Nutanix Announces Date and Conference Call Information for Fiscal Fourth Quarter and Fiscal Year 2025 Financial Results
GlobeNewswire
·
August 7, 2025
SAN JOSE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the fiscal fourth quarter and fiscal year 2025, which ended July 31, …
BioAtla Reports Second Quarter 2025 Financial Results and Highlights Recent Progress
GlobeNewswire
·
August 7, 2025
CAB-EpCAM x CAB-CD3 bispecific T-cell engager (TCE) (BA3182) Phase 1 dose-escalation study ongoing, currently dosing 1.2 mg cohort; Phase 1 data readout expected 2H 2025 Fast Track Designated Ozuriftamab vedotin (Oz-V; CAB-ROR2-ADC) Phase 2 study ongoing; …